Brandtree

Who owns QG5?

QG5 is made and sold by Genomma Lab (Mexico, BMV: LAB) under licence, an arrangement in place since 2009; Genomma Lab does not own the name.[1] The name is owned by another company.

Key facts

Licensed to
Genomma Lab Internacional, S.A.B. de C.V. reported
Since
Headquarters
🇲🇽 Mexico, Mexico City
Origin
🇲🇽 Mexico
Category
Consumer healthOver-the-counter medicineDigestive health
Parent ticker
BMV: LAB
Last verified
· 1 sources

About QG5

QG5 is an over-the-counter treatment for colitis that Genomma Lab has sold since 2009, when it bought the licensee rights to the name rather than the name itself, in the same transaction that gave it cosmetic rights to Sanborns. It is one of the more widely distributed products in the portfolio, listed for sale in Argentina, Brazil, Central America and the Caribbean, Chile, Peru and Bolivia as well as Mexico.

Ownership timeline of QG5

Where QG5 sits in Genomma Lab

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where QG5 sits in Genomma Lab Tree of 13 brands under Genomma Lab. Genomma Lab Asepxia Bufferin (United States) Cicatricure Kaopectate Nikzon Pomada de la Campana and 7 more

Open the full Genomma Lab ownership tree →

Other brands handled by Genomma Lab in consumer health

See the full Genomma Lab brand portfolio (13) →

Latest news about QG5

No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.

Headlines link to the original publisher. Brandtree does not reproduce article text.

Frequently asked questions

Who makes QG5?

Genomma Lab makes and sells QG5 under a licensing agreement that has been in place since 2009.

Does Genomma Lab own QG5?

No. Genomma Lab holds a licence to make and sell QG5, which is not the same as owning it.

Where did QG5 come from?

QG5 originated in Mexico.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.